Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
324 results about "Insulin pump" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy. The device configuration may vary depending on design.
Implantable sensor
InactiveUS6895265B2Thickness minimizationTransport of glucose to the sensor is not altered over timeStentsCatheterAnalyteInsulin pump
A sensor is disclosed, for implantation within a blood vessel to monitor an analyte in blood. In one embodiment, the analyte is glucose. A signal indicative of glucose level is transmitted to an external receiver. The signal may also be used to drive an internal or externally worn insulin pump. Methods are also disclosed.
Owner:SILVER JAMES H
Programmable insulin pump
Owner:TANDEM DIABETES CARE INC
Method and system for providing integrated medication infusion and analyte monitoring system
InactiveUS20060224141A1Drug and medicationsPharmaceutical delivery mechanismMedication infusionAnalyte
Method and system for integrating infusion device and analyte monitoring system including medication infusion device such as an insulin pump and an analyte monitoring system such as a glucose monitoring system are provided.
Owner:ABBOTT DIABETES CARE INC
Implantable sensor
InactiveUS7033322B2Thickness minimizationTransport of glucose to the sensor is not altered over timeStentsCatheterAnalyteInsulin pump
A sensor is disclosed, for implantation within a blood vessel to monitor an analyte in blood. In one embodiment, the analyte is glucose. A signal indicative of glucose level is transmitted to an external receiver. The signal may also be used to drive an internal or externally worn insulin pump. Methods are also disclosed.
Owner:SILVER JAMES H
Medical infusion pump capable of learning bolus time patterns and providing bolus alerts
ActiveUS6999854B2Drug and medicationsPharmaceutical delivery mechanismInsulin pumpEmergency medicine
Owner:TANDEM DIABETES CARE INC
Apparatus and methods using acoustic telemetry for intrabody communications
Systems and methods provide intrabody communication using acoustic telemetry. The system includes a first or control implant including a first acoustic transducer, and a second implant including a switch and a second acoustic transducer coupled to the switch. The second acoustic transducer receives acoustic signals from the first acoustic transducer for closing the switch to activate the second implant. The second implant may include a sensor for measuring a physiological parameter that is transmitted using acoustic signals including the physiological data to the first implant. For example, the second implant may measure pressure in the patient's heart that may be used by the first implant to control a pacemaker. Alternatively, the second implant may blood sugar concentration that may be used by the first implant to control an insulin pump. Alternatively, the first implant may store and transfer the data to an external device for monitoring the patient.
Owner:REMON MEDICAL TECH
Glucose measuring device integrated into a holster for a personal area network device
A glucose meter module integrated into a holster device that can securely accommodate another device such as a portable server device or an insulin pump is described. The glucose measuring module and the health device communicate with each other by a short range wireless modality. In the case in which the accommodated device is a server, such as personal digital assistant or cell phone, the device stores data in a memory, displays data on a visual display, and can wirelessly transmit such data to other devices within a personal area network. In the case where the accommodated device is a cell phone, the phone can further transmit data to remote sites. In the case where the accommodated device is an insulin pump, wirelessly received data are stored in a memory, are available for visual display on the insulin pump, and can be incorporated into the electronic processes that regulate the performance of the pump.
Owner:THERASENSE
Method for controlling insulin pump using Bluetooth protocol
A method for controlling an insulin pump using the Bluetooth protocol. The method comprises allocating IDs to insulin pumps and blood sugar level measuring devices, respectively; checking, in a corresponding insulin pump, whether or not blood sugar level data is inputted from a blood sugar level measuring device having a corresponding ID; cumulating inputted data and judging whether or not abnormality occurs; generating a command to allow the insulin pump to operate as it is, when abnormality did not occur; generating a command to change an insulin injection amount of the insulin pump when abnormality occurred, and then, returning to the third step; and determining a system to be out of order when data is not inputted in the checking step, and generating an alarm so that a qualified person can visit a corresponding patient to have a trouble to be directly addressed.
Owner:CHOI SOO BONG
Methods of determining pre or post meal time slots or intervals in diabetes management
A diabetes management system or process is provided herein that may be used to analyze and recognize patterns for a large number of blood glucose concentration measurements and other physiological parameters related to the glycemia of a patient. In particular, a method of monitoring glycemia in a patient may include storing a patient's data on a suitable device, such as, for example, a blood glucose meter. The patient's data may include blood glucose concentration measurements. The diabetes management system or process may be installed on, but is not limited to, a personal computer, an insulin pen, an insulin pump, or a glucose meter. The diabetes management system or process may identify a plurality of pattern types from the data including a testing / dosing pattern, a hypoglycemic pattern, a hyperglycemic pattern, a blood glucose variability pattern, and a comparative pattern. After identifying a particular pattern with the data management system or process, a warning message may be displayed on a screen of a personal computer or a glucose meter. Other messages can also be provided to ensure compliance of any prescribed diabetes regiments or to guide the patient in managing the patient's diabetes.
Owner:LIFESCAN INC
Insulin pump for use in conjunction with mobile communication terminal capable of measuring blood glucose levels and network system for transmitting control information for insulin pump
InactiveUS20070060796A1Improve ease of useAccurate supplyDrug and medicationsMedical devicesKey pressingMotor drive
An insulin pump for use in conjunction with a mobile communication terminal capable of measuring a blood glucose level, and a network for transmitting control information for the insulin pump are disclosed. The insulin pump includes an external input port, an output port, memory, a key input unit, a control unit, and a motor driver. The external input port receives information on the amounts of insulin to be injected. The output port outputs information on the amounts of insulin injected. The memory stores the information on the amounts of insulin injected. The key input unit inputs the status of a user. The control unit extracts the information on the amounts of insulin to be injected from the memory. The motor drive operates a soft motor to supply insulin.
Owner:KIM YOON NYUN
Drive unit for medical devices
InactiveUS20080007141A1Produce extremely low noiseImprove efficiencyPiezoelectric/electrostriction/magnetostriction machinesDiagnostic recording/measuringInsulin pumpActuator
The invention relates to a drive unit for a medical device such as an insulin pump, lancing device, or test strip magazine. The drive unit comprises an actuator for charging a mechanical energy storage element. The actuator oscillates and executes travel strokes which are transmitted by means of a step-up element to a nonreturn rotor or traveler for prestressing the mechanical energy storage element and driving a movement element.
Owner:ROCHE DIABETES CARE INC
Insulin pump with insulin therapy coaching
An apparatus comprising a pump configured to deliver insulin, an input configured to receive information related to managing diabetes of a user, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes an insulin timing module configured to initiate delivery of insulin in a time relation to when a meal is to be consumed by the user and to adjust delivery of the insulin according to the received information. Other devices, systems, and methods are disclosed.
Owner:SMITHS MEDICAL ASD INC
Insulin pump based expert system
An apparatus comprising a pump configured to deliver insulin, an input configured to receive blood glucose data, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a blood glucose data module to compare the blood glucose data to a target blood glucose level for an insulin pump user. The controller is configured to present a question related to the blood glucose level via the user interface when the blood glucose level is different than the target blood glucose level, receive a response to the question via the user interface, and present a recommended user action based at least in part on the response. Other devices, systems, and methods are disclosed.
Owner:TANDEM DIABETES CARE INC
System and method for detecting hypoglycemia based on a paced depolarization integral using an implantable medical device
ActiveUS20060247685A1Improve blood sugar controlReduce deliveryElectrocardiographyMedical devicesCardiac pacemaker electrodeInsulin dependent
Techniques are provided for use with an implantable medical device such as a pacemaker or implantable cardioverter / defibrillator (ICD) for predicting and detecting hypoglycemia. In one example, the device tracks changes in a paced depolarization integral (PDI). A significant increase in PDI over a relatively short period of time indicates the onset of hypoglycemia (this can also be confirmed with QT changes). Upon detection of hypoglycemia, appropriate warning signals are generated to alert the patient. Certain therapies automatically provided by the implantable device may also be controlled in response to hypoglycemia. For example, if the patient is an insulin-dependent diabetic and the implantable device is equipped with an insulin pump capable of delivering insulin directly into the bloodstream, insulin delivery is automatically suspended until blood glucose levels return to acceptable levels. If the device is an ICD, it may be controlled to begin charging defibrillation capacitors upon detection of hypoglycemia so as to permit prompt delivery of a defibrillation shock, which may be needed if hypoglycemia triggers ventricular fibrillation. The detection techniques may be used in conjunction with other hypoglycemia detection techniques to improve detection specificity.
Owner:PACESETTER INC
Method and apparatus for providing sensor guard for data monitoring and detection systems
InactiveUS20070135697A1Reduce the possibilityEliminate potential adverse resultCatheterDiagnostic recording/measuringEquipotentialInsulin pump
Method and apparatus for providing sensor guard for data monitoring and detection system having a sensor for detecting one or more glucose levels, the sensor including a work electrode disposed on a base material, a reference electrode disposed on the base material, and a guard electrode disposed on the base material, where the guard electrode is maintained substantially at equipotential to the work electrode, and a transmitter operatively coupled to the work electrode and the reference electrode of the sensor for receiving said detected glucose levels, where the transmitter is further configured to transmit a respective signal corresponding to each of the detected glucose levels using a data transmission protocol including wireless data transmission protocols, to a receiver which is configured to receive the transmitted signals corresponding to said detected glucose levels is provided. The method and apparatus may also include insulin administration unit such as an insulin pump configured to be in data communication with the transmitter and / or the receiver for administering an appropriate insulin dosage based on the measured glucose levels.
Owner:ABBOTT DIABETES CARE INC
System and method for monitoring blood glucose levels using an implantable medical device
ActiveUS7029443B2Reliable levelingImprove the level ofElectrocardiographyHeart stimulatorsT waveQT interval
T-wave amplitude and QT interval are derived from patient cardiac signals. Then blood glucose levels are determined based on a combination of the T-wave amplitude and the QT interval. By using a combination of both T-wave-based and QT interval-based signals, blood glucose levels can be reliably detected throughout a wide range of blood glucose levels. Once the blood glucose level has been detected, the implanted device compares the blood glucose level against upper and lower acceptable bounds and appropriate warning signals are generated if the level falls outside the bounds. In one example, wherein an implantable insulin pump is additionally provided, the pump is controlled based on the detected blood glucose level to maintain glucose levels within an acceptable range. A calibration technique is also provided for determining patient-specific parameters for use in the detection of blood glucose levels.
Owner:PACESETTER INC
Analyzing wireless communication degradation through comparison of communication links
ActiveUS20110058485A1Error preventionFrequency-division multiplex detailsGlucose sensorsTelecommunications link
A system and method of processing information regarding medical devices in wireless communication with each other is provided in which a handheld device has a first wireless communication link with a first medical device, such as a glucose sensor, and a second wireless communication link with a second medical device, such as an insulin pump. A processor in the handheld device monitors the status of the first and second wireless links and upon noting a change in status of either one, compares the first wireless link status with the second wireless link status and provides guidance for resolving a communication problem based on the comparison. The latency of the medical devices is considered as well as the ability to make system status changes, extend time periods before alarms are issued, and the characteristics of the medical devices are considered.
Owner:ABBOTT DIABETES CARE INC
Method and System for Providing Integrated Medication Infusion and Analyte Monitoring System
ActiveUS20100076412A1Drug and medicationsPharmaceutical delivery mechanismMedication infusionAnalyte
Method and system for integrating infusion device and analyte monitoring system including medication infusion device such as an insulin pump and an analyte monitoring system such as a glucose monitoring system are provided.
Owner:ABBOTT DIABETES CARE INC
Expert system for insulin pump therapy
An apparatus comprising a controller. The controller includes an input / output (I / O) module and a rule module. The I / O module is configured to present a question for a patient when communicatively coupled to a user interface and receive patient information in response to the question via the user interface. The rule module is configured to apply a rule to the patient information and generate a suggested insulin pump setting from application of the rule. Other devices, systems, and methods are disclosed.
Owner:TANDEM DIABETES CARE INC
Device for optical monitoring of constituent in tissue or body fluid sample using wavelength modulation spectroscopy, such as for blood glucose levels
InactiveUS7356364B1Improve signal-to-noise ratioReduce calculationMedical devicesCatheterConcentrations glucosePhotodetector
A device for monitoring the concentration level of a constituent in tissue or a body fluid sample, such as glucose concentration in blood, has a laser light source which is modulated about a center emission frequency to probe the absorption spectrum of the constituent being monitored, a laser driver circuit for tuning and modulating the laser light, a photodetector for detecting light from the laser light source transmitted through the sample as the modulation frequency of the laser is tuned, and a demodulator for demodulating the transmitted light and detecting variations in magnitude at harmonics of the modulation frequency to assess the concentration level of that constituent. The device utilizes short-wavelength near-infrared laser light to monitor blood glucose levels, and could also be used for drug screening and diagnosis of other medical conditions as well. In one embodiment, the device is used to monitor blood glucose level externally from the body and non-invasively by trans-illumination through a thin layer of skin, without the need for physical penetration of the skin. In another embodiment, the device is used as an intravenous sensor deployed through a catheter, and its output can be used to control an insulin pump to stabilize the patient's blood glucose levels.
Owner:UNIV OF HAWAII
System and method for monitoring blood glucose levels using an implantable medical device
ActiveUS7016720B2Optimal blood glucose levelReliable levelingElectrocardiographyHeart stimulatorsT waveQT interval
T-wave amplitude and QT interval are derived from patient cardiac signals. Then blood glucose levels are determined based on a combination of the T-wave amplitude and the QT interval. By using a combination of both T-wave-based and QT interval-based signals, blood glucose levels can be reliably detected throughout a wide range of blood glucose levels. Once the blood glucose level has been detected, the implanted device compares the blood glucose level against upper and lower acceptable bounds and appropriate warning signals are generated if the level falls outside the bounds. In one example, wherein an implantable insulin pump is additionally provided, the pump is controlled based on the detected blood glucose level to maintain glucose levels within an acceptable range. A calibration technique is also provided for determining patient-specific parameters for use in the detection of blood glucose levels.
Owner:PACESETTER INC
Insulin pump based expert system
An apparatus comprising a pump configured to deliver insulin, an input configured to receive blood glucose data, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a blood glucose data module to compare the blood glucose data to a target blood glucose level for an insulin pump user. The controller is configured to present a question related to the blood glucose level via the user interface when the blood glucose level is different than the target blood glucose level, receive a response to the question via the user interface, and present a recommended user action based at least in part on the response. Other devices, systems, and methods are disclosed.
Owner:TANDEM DIABETES CARE INC
Kalman Filter Based On-Off Switch for Insulin Pump
ActiveUS20140221966A1Mitigate and prevent low blood glucose levelLower blood sugar levelsElectrocardiographyMedical devicesKaiman filterInsulin pump
Techniques for controlling an insulin pump include determining values for parameters selected from a group including a first prediction time horizon, a predicted glucose threshold (Goff) for turning the insulin pump off, a maximum shut off time within a time window, and duration of the time window. A safety rule is determined based on the maximum shut off time within the duration. Glucose readings are collected up to a current time. An expected current glucose value G and glucose temporal rate of change are determined based only on the glucose readings and a Kalman filter configured for noisy glucose readings. A glucose level (Gh1) is predicted for a future time that is the prediction time horizon after the current time. A command is issued to shut off the insulin pump if it is determined both that Gh1 is less than Goff and that the safety rule is satisfied.
Owner:UNIV OF COLORADO THE REGENTS OF +3
Clinical variable determination
A computer implemented method of determining a clinical variables utilizing an insulin pump that includes initiating blood glucose measurements, initiating ingestion of carbohydrates and receiving input data based on the blood glucose measurements and the ingestion of carbohydrates and utilizing the data to calculate clinical variables. The invention may include presenting instructions to a patient to take various actions and to input various data. The clinical variables determined may be stored in memory and then used to calculate insulin doses and to send a signal to an insulin pump to infuse the insulin dose calculated.
Owner:TANDEM DIABETES CARE INC
Insulin pump having missed meal bolus alarm
A pump for delivering insulin to a user. The pump comprises a pump mechanism and a meal-bolus program module. The meal-bolus program module is programmed to control the pump mechanism to deliver a meal bolus. An alarm program module is in data communication with the alarm, the timer, and the meal-bolus program module. The alarm module is programmed to generate an alarm signal when the meal-bolus program module does not control the pump mechanism to deliver a meal bolus within a predetermined period of time.
Owner:DELTEC
Insulin pump with convenience features
This document discusses, among other things, an apparatus comprising a pump configured to deliver insulin, a user interface including a display, and a controller communicatively coupled to the pump and the user interface. The controller includes a site display module configured to display a next suggested location of the body for the user to use in treating diabetes from a series of suggested body locations.
Owner:SMITHS MEDICAL ASD INC
Method, system, and computer program for performing carbohydrate/insulin calculation based upon food weight
InactiveUS20050187749A1Computation using non-contact making devicesAnalogue computers for chemical processesAdditive ingredientElectron
A technique is disclosed by which a weight scale, having electronic output, is couplable to a processing device such as a computer, and preferably, a hand-held computer, PDA, cell phone or the like. The processing device is configured to receive weight inputs from the weight scale and identification information of the food or food ingredients being weighed, and then convert the gram weight of the food into grams of carbohydrate and protein for that food. For diabetes applications, the process also converts the carbohydrate and protein information into rapid-acting insulin dosages which can then be used to determine manually the amount of insulin to be dosed to the person with diabetes. In a preferred embodiment, the calculated insulin dosages information is automatically provided to a insulin pump or other automatic means of dosing insulin to a patient to thereby automatically dose the patient properly.
Owner:SINGLEY JUDY
Method for controlling insulin pump through internet
Owner:CHOI SOO BONG
Apparatus and methods using acoustic telemetry for intrabody communications
InactiveUS20070142728A1Facilitate communicationElectrotherapySurgeryCommunications systemCardiac pacemaker electrode
Systems and methods provide intrabody communication using acoustic telemetry. The system includes a first or control implant including a first acoustic transducer, and a second implant including a switch and a second acoustic transducer coupled to the switch. The second acoustic transducer receives acoustic signals from the first acoustic transducer for closing the switch to activate the second implant. The second implant may include a sensor for measuring a physiological parameter that is transmitted using acoustic signals including the physiological data to the first implant. For example, the second implant may measure pressure in the patient's heart that may be used by the first implant to control a pacemaker. Alternatively, the second implant may blood sugar concentration that may be used by the first implant to control an insulin pump. Alternatively, the first implant may store and transfer the data to an external device for monitoring the patient.
Owner:REMON MEDICAL TECH
Fibrillation-resistant insulin and insulin analogues
InactiveUS20100099601A1Promote absorptionRapidity of absorptionFungiSugar derivativesInsulin pumpInsulin receptor binding
A fibrillation-resistant insulin analogue may be a single-chain insulin analogue or a physiologically acceptable salt thereof, containing an insulin A chain sequence or an analogue thereof and an insulin B chain sequence or an analogue thereof connected by a polypeptide of 4-10 amino acids. The fibrillation-resistant insulin analogue preferably displays less than 1 percent fibrillation with incubation at 37° C. for at least 21 days. A single-chain insulin analogue displays greater in vitro insulin receptor binding than normal insulin while displaying less than or equal binding to IGFR than normal insulin. The fibrillation-resistant insulin may be used to treat a patient using an implantable or external insulin pump, due to its greater fibrillation resistance.
Owner:CASE WESTERN RESERVE UNIV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com